JP2024513700A5 - - Google Patents
Info
- Publication number
- JP2024513700A5 JP2024513700A5 JP2023556746A JP2023556746A JP2024513700A5 JP 2024513700 A5 JP2024513700 A5 JP 2024513700A5 JP 2023556746 A JP2023556746 A JP 2023556746A JP 2023556746 A JP2023556746 A JP 2023556746A JP 2024513700 A5 JP2024513700 A5 JP 2024513700A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- seq
- acid sequence
- mutation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163162199P | 2021-03-17 | 2021-03-17 | |
| US63/162,199 | 2021-03-17 | ||
| US202163195536P | 2021-06-01 | 2021-06-01 | |
| US63/195,536 | 2021-06-01 | ||
| PCT/CA2022/050400 WO2022193017A1 (en) | 2021-03-17 | 2022-03-16 | Anti-vaccinia virus antigen antibodies and related compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513700A JP2024513700A (ja) | 2024-03-27 |
| JP2024513700A5 true JP2024513700A5 (https=) | 2025-03-21 |
Family
ID=83322196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023556746A Pending JP2024513700A (ja) | 2021-03-17 | 2022-03-16 | 抗ワクシニアウイルス抗原抗体並びに関連する組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240309070A1 (https=) |
| EP (1) | EP4308601A4 (https=) |
| JP (1) | JP2024513700A (https=) |
| KR (1) | KR20240006506A (https=) |
| AU (1) | AU2022241385A1 (https=) |
| CA (1) | CA3211935A1 (https=) |
| MX (1) | MX2023010848A (https=) |
| WO (1) | WO2022193017A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3154214A1 (en) * | 2019-09-13 | 2021-03-18 | adMare Therapeutics Society | Anti-oncolytic virus antigen antibodies and methods of using same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007075914A2 (en) * | 2005-12-22 | 2007-07-05 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Monoclonal antibodies against orthopoxviruses |
| CN101553255A (zh) * | 2006-08-23 | 2009-10-07 | 奎尔斯根制药有限责任公司 | 天花单克隆抗体 |
| CA3154214A1 (en) * | 2019-09-13 | 2021-03-18 | adMare Therapeutics Society | Anti-oncolytic virus antigen antibodies and methods of using same |
| EP4061121A1 (en) * | 2019-11-22 | 2022-09-28 | Gallagher Eshepherd Pty Ltd | Wearable electronic collar for animals |
-
2022
- 2022-03-16 US US18/282,507 patent/US20240309070A1/en active Pending
- 2022-03-16 JP JP2023556746A patent/JP2024513700A/ja active Pending
- 2022-03-16 KR KR1020237034917A patent/KR20240006506A/ko active Pending
- 2022-03-16 WO PCT/CA2022/050400 patent/WO2022193017A1/en not_active Ceased
- 2022-03-16 AU AU2022241385A patent/AU2022241385A1/en not_active Abandoned
- 2022-03-16 EP EP22770138.0A patent/EP4308601A4/en active Pending
- 2022-03-16 MX MX2023010848A patent/MX2023010848A/es unknown
- 2022-03-16 CA CA3211935A patent/CA3211935A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Research progress and applications of multivalent, multispecific and modified nanobodies for disease treatment | |
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| JP2022548043A5 (https=) | ||
| JP4794301B2 (ja) | 抗体の製造方法 | |
| CN110229232B (zh) | 双特异性抗体及其用途 | |
| JP7711208B2 (ja) | Ｄｌｌ３に対する結合分子及びその使用 | |
| WO2013085972A1 (en) | Pdgf receptor beta binding polypeptides | |
| JP7433236B2 (ja) | 抗葉酸受容体１抗体及びその使用 | |
| MX2010011955A (es) | Inmunoglobulinas de dominio variable doble y usos de las mismas. | |
| EP3310816B1 (en) | Cys80 conjugated immunoglobulins | |
| JP7099709B2 (ja) | ヒト化抗ベイシジン抗体およびその使用 | |
| JP2024514109A (ja) | 抗ｃｎｔｎ４抗体及びその使用 | |
| JP2024513700A5 (https=) | ||
| CA2799217A1 (en) | Recombinantly produced antibodies targeting erbb signaling molecules and methods of use thereof for the diagnosis and treatment of disease | |
| CN120943966A (zh) | TriAx抗体的组合物及其制备和使用方法 | |
| CN117177999A (zh) | 一种靶向IL-18Rβ的抗体及其应用 | |
| US20230406929A1 (en) | Polypeptide constructs binding to cd3 | |
| CN118754989B (zh) | 一种抗her2纳米抗体及其制备方法和应用 | |
| US20230406887A1 (en) | Antigen binding domain with reduced clipping rate | |
| JP2026506070A (ja) | 抗ｃｎｔｎ４抗体及びその使用 | |
| CN105229034B (zh) | 用于与抗体药物偶联物疗法一起使用的免疫成像剂 | |
| JP2023536630A5 (https=) | ||
| JP2023548471A5 (https=) | ||
| Ebrahimi et al. | Nanobody as a New Generation of Functional Proteins: Nanobody as a new functional domains | |
| EP4663661A1 (en) | Anti-cdh6 antibody and use thereof |